It will be extremely interesting to determine whether this histological transformation from NSCLC to SCLC upon acquired EGFR-inhibitor resistance is the result of a functional switch from ITGA2-ITGB6 to ITGA2-ITGB2 during EGFR complex formation. The gene discussed is ITGA2; the disease is small cell lung carcinoma.